Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 12, Issue 4, Pages 401-417
Publisher
Informa UK Limited
Online
2014-03-03
DOI
10.1586/14787210.2014.894881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term prognosis in community-acquired pneumonia
- (2013) Marcos I. Restrepo et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Does Empiric Therapy for Atypical Pathogens Improve Outcomes for Patients with CAP?
- (2013) Thomas M. File et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- What Is the Relevance of Antimicrobial Resistance on the Outcome of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae? (Should Macrolide Monotherapy Be Used for Mild Pneumonia?)
- (2013) Donald E. Low INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment
- (2013) Seo Yun Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan
- (2012) Chun-Hsing Liao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A liquid chromatography-tandem mass spectrometry assay for the determination of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single-dose pharmacokinetic study in healthy Chinese volunteers
- (2012) Beining Guo et al. BIOMEDICAL CHROMATOGRAPHY
- Cardiac Complications in Patients With Community-Acquired Pneumonia
- (2012) Vicente F. Corrales-Medina et al. CIRCULATION
- Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses
- (2012) Beining Guo et al. CLINICAL DRUG INVESTIGATION
- Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
- (2012) Leyla Asadi et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of Methicillin-Resistant Staphylococcus aureus as an Etiology of Community-Acquired Pneumonia
- (2012) G. J. Moran et al. CLINICAL INFECTIOUS DISEASES
- Does Empirical Therapy with a Fluoroquinolone or the Combination of a β-Lactam Plus a Macrolide Result in Better Outcomes for Patients Admitted to the General Ward?
- (2012) Jörg Ruhe et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- How Important is Methicillin-Resistant Staphylococcus aureus as a Cause of Community-Acquired Pneumonia and What is Best Antimicrobial Therapy?
- (2012) Richard G. Wunderink INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Community-Acquired Pneumonia Guidelines: A Global Perspective
- (2012) Michael Niederman et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis
- (2012) Robert Wilson et al. Expert Review of Respiratory Medicine
- Multicenter Study in Taiwan of theIn VitroActivities of Nemonoxacin, Tigecycline, Doripenem, and Other Antimicrobial Agents against Clinical Isolates of Various Nocardia Species
- (2011) Chih-Cheng Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibilities and Molecular Epidemiology of Clinical Isolates ofClostridium difficilein Taiwan
- (2011) Yi-Chun Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnostic Tests for Agents of Community-Acquired Pneumonia
- (2011) John G. Bartlett CLINICAL INFECTIOUS DISEASES
- Guidelines for the management of adult lower respiratory tract infections - Full version
- (2011) M. Woodhead et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010
- (2011) W. L. Liu et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
- (2011) S. Ewig et al. EUROPEAN RESPIRATORY JOURNAL
- Microbial aetiology of community-acquired pneumonia and its relation to severity
- (2011) C. Cilloniz et al. THORAX
- Cardiac Complications in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies
- (2011) Vicente F. Corrales-Medina et al. PLOS MEDICINE
- Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
- (2010) M. R. Jacobs et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
- (2010) D. J. J. van Rensburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
- (2010) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998–2007
- (2010) J.-C. Yang et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Levofloxacin in the treatment of community-acquired pneumonia
- (2010) Ayman M Noreddin et al. Expert Review of Anti-Infective Therapy
- In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone
- (2010) C.-R. Li et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Study of community-acquired pneumonia: Incidence, patterns of care, and outcomes in primary and hospital care
- (2010) Alberto Capelastegui et al. JOURNAL OF INFECTION
- Trends in Mortality and Medical Spending in Patients Hospitalized for Community-Acquired Pneumonia
- (2010) Gregory W. Ruhnke et al. MEDICAL CARE
- Burden of Community-Acquired Pneumonia in North American Adults
- (2010) Thomas M. File et al. POSTGRADUATE MEDICINE
- Management of community-acquired pneumonia: a review and update
- (2010) Navdeep K. Brar et al. Therapeutic Advances in Respiratory Disease
- Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia
- (2009) Devorah J. Nazarian et al. ANNALS OF EMERGENCY MEDICINE
- Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers
- (2009) D. T. Chung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Nemonoxacin (TG-873870), a Novel Potent Broad-Spectrum Nonfluorinated Quinolone, in Healthy Volunteers
- (2009) L. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
- (2009) H. J. Adam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Etiology of Community‐Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
- (2009) Niclas Johansson et al. CLINICAL INFECTIOUS DISEASES
- Nemonoxacin
- (2009) A. Arjona et al. DRUGS OF THE FUTURE
- Impact of intravenous -lactam/macrolide versus -lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia
- (2009) A. Tessmer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis
- (2009) C.-K. Tan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species
- (2009) Chih-Cheng Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan
- (2009) Y.-H. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Geography and the aetiology of community-acquired pneumonia
- (2009) RESPIROLOGY
- New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
- (2009) S Ewig et al. THORAX
- Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials
- (2008) K. Z. Vardakas et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Is Activity against “Atypical” Pathogens Necessary in the Treatment Protocols for Community‐Acquired Pneumonia? Issues with Combination Therapy
- (2008) John G. Bartlett CLINICAL INFECTIOUS DISEASES
- Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis
- (2008) N. Maimon et al. EUROPEAN RESPIRATORY JOURNAL
- Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia
- (2008) Jennie Johnstone et al. MEDICINE
- Ibis T5000: a universal biosensor approach for microbiology
- (2008) David J. Ecker et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More